Autologous genetically engineered NY-ESO-1(c259)T in HLA-A*02:01, HLA*02:05 and HLA*02:06 positive patients with NY-ESO-1 expressing tumors Meeting Abstract
| Authors: | Mackall, C.; D'Angelo, S. P.; Grupp, S. A.; Odunsi, K.; Cristea, M. C.; Linette, G. P.; Kluger, H. M.; Kari, G.; Pandite, L.; Holdich, T.; Norry, E.; Binder-Scholl, G.; Amado, R. G. |
| Abstract Title: | Autologous genetically engineered NY-ESO-1(c259)T in HLA-A*02:01, HLA*02:05 and HLA*02:06 positive patients with NY-ESO-1 expressing tumors |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 166s |
| Language: | English |
| ACCESSION: | WOS:000404665404138 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS3101 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS3101 -- Source: Wos |
